Table 2. Bodyweights of all groups of rats during the experiments.
| Time |
Blood glucose (mmol/l) |
||||||
|---|---|---|---|---|---|---|---|
| Group I | Group II | Group III | Group IV | Group V | Group VI | Group VII | |
| 72 h |
6.8±0.6 (n=5) |
29.2±6.1 (n=9) |
30.5±6.3 (n=9) |
31.0±2.9 (n=9) |
28.0±6.5 (n=9) |
32.6±1.0 (n=9) |
29.8±4.2 (n=14) |
| 4 wk |
5.8±0.3 (n=5) |
29.7±8.6 (n=8) |
28.2±8.7 (n=7) |
31.7±2.5 (n=9) |
28.49±7.8 (n=8) |
33.0±0.5 (n=9) |
27.0±8.1 (n=13) |
| 8 wk |
6.2±0.6 (n=5) |
29.3±8.4 (n=8) |
27.5±11.6 (n=7) |
29.2±3.8 (n=9) |
27.3±9.3 (n=8) |
30.1±2.6 (n=8) |
28.2±5.7 (n=13) |
| 12 wk |
5.78±1.1 (n=5) |
29.2±9.0 (n=7) |
25.1±13.1 (n=5) |
30.7±3.7 (n=8) |
26.7±9.7 (n=7) |
30.0±3.4 (n=6) |
28.7±6.3 (n=10) |
| 13 wk | 5.9±0.9 (n=5) | 29.5±9.4 (n=7) | 24.8±13.4 (n=5) | 32.4±1.6 (n=7) | 27.7±10.2 (n=7) | 29.6±5.2 (n=5) | 28.5±6.8 (n=10) |
The data are the mean±SD. Blood glucose levels in all groups of diabetic rats (Group II−VII) were significantly higher than in the normal rats (Group I). There were no significant differences between the six diabetic groups at any given stage (Group II−VII). Group I: Normal; Group II: Carnosine treated (5 mg/ml); Group III: Carnosine treated (10 mg/ml); Group IV: Aspirin treated; Group V: Aminoguanidine treated (1 mg/ml); Group VI: Aminoguanidine treated (2 mg/ml); and Group VII: Untreated diabetic.